Traditionally, breast cancer is treated based on the expression of estrogen receptor (ER), progesterone receptor (PR), and/or human epidermal growth factor 2 (HER2) receptor using endocrine and HER2 targeting therapies, respectively. Here, PGR is linked to breast carcinoma.